MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xhgg.2025.100477

Медицинская библиотека · HGG advances · 2025

Polygenic risk scores for prostate cancer: Comparative evaluations in UK and Australian cohorts.

Tanha Hamzeh M, Law Matthew H, Ingold Nathan, Ly Philip, Olsen Catherine M, Pandeya Nirmala, Smith David P, MacInnis Robert J, Whiteman David C, Cust Anne E, Steinberg Julia

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

Risk-based approaches offer promise for enhancing early detection of prostate cancer. Polygenic risk scores (PGSs) have emerged as a potential approach for risk stratification, though their performance varies by population. We evaluated nine PGSs (four existing, five new) for predicting 5-year prostate cancer risk across three international population-based prospective cohorts: UK Biobank (UKB), the Australian QSkin Sun and Health Study (QSkin), and Melbourne Collaborative Cohort Study (MCCS). We analyzed UKB European-ancestry (n = 184,010), South-Asian-ancestry (n = 5,097), and African-ancestry (n = 3,193), QSkin European-ancestry (n = 6,791), and MCCS European-ancestry (n = 1,809) male participants. We estimated age-specific 5-year prostate cancer risks (from population data) and PGS-adjusted risks (age-specific risks multiplied by PGS-based relative risks). Predictive performance was assessed using discrimination (AUC) and calibration. PGS significantly enhanced 5-year risk prediction over age alone, particularly for European ancestry (AUC increase 0.05-0.12, p < 10-6). PGS performance was consistent across European-ancestry men in Australian and UK cohorts, and by pre-baseline prostate-specific antigen tests and family history in UKB. No single PGS outperformed others across all cohorts and ancestry groups. As an illustrative example for potential risk stratification, for a leading PGS in both Australian cohorts, we estimated the population-average 5-year risk at age 50 was reached 5 years earlier by individuals with 20% highest PGS451 and 5 years later by those with 20% lowest PGS451. In conclusion, rigorous analyses with consistent results from international cohorts support the potential of PGS to improve 5-year prostate cancer risk prediction. In the future, PGS may be improved further to enhance performance in diverse populations.

Для цитирования: Tanha Hamzeh M, Law Matthew H, Ingold Nathan, Ly Philip, Olsen Catherine M, Pandeya Nirmala, Smith David P, MacInnis Robert J, Whiteman David C, Cust Anne E, Steinberg Julia. Polygenic risk scores for prostate cancer: Comparative evaluations in UK and Australian cohorts.. HGG advances. 2025. DOI: 10.1016/j.xhgg.2025.100477.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.